Patents Assigned to Yale University
-
Publication number: 20240138269Abstract: Techniques are described to construct an electromagnetic resonator by arranging a resonant structure within a super-conducting cavity. The architecture of the design may provide a low loss superconducting cavity resonator that may exhibit multiple modes. The multimode nature of this resonator is produced in part by the resonant structure in such a way that allows the modes of the resonator to be adjusted through adjustment of the resonant structure rather than by having to alter the physical dimensions of the cavity, as would otherwise be required in a conventional superconducting cavity resonator. In some embodiments, the resonant structure may include a suspended superconductor comprising metal and/or metallized parts.Type: ApplicationFiled: February 17, 2022Publication date: April 25, 2024Applicant: Yale UniversityInventors: Chan U Lei, Suhas Ganjam, Lev Krayzman, Robert J. Schoelkopf lll, Luigi Frunzio
-
Patent number: 11964233Abstract: The present disclosure relates, in part, to enhanced weathering systems and/or apparatuses and methods of use thereof. In one aspect, the present disclosure provides a method of at least partially sequestering CO2 from an influent aqueous solution comprising aqueous and/or gaseous CO2. In another aspect, the present disclosure provides a method of at least partially sequestering CO2 from a gaseous CO2 source. In another aspect, the present disclosure provides systems and/or apparatuses suitable for use in the methods described herein. In another aspect, the present disclosure provides a method of optimizing the design and operation of a system for at least partial sequestration of CO2 from a water source.Type: GrantFiled: April 10, 2023Date of Patent: April 23, 2024Assignee: YALE UNIVERSITYInventors: Joachim Katchinoff, Noah Planavsky, Jacob Jordan, Dean Takahashi, Sinead Crotty, Justin Freiberg
-
Patent number: 11965218Abstract: The present disclosure concerns methods of detecting viral respiratory infections by analyzing biomarkers in a viral transport medium sample. In various embodiments the biomarkers are assessed by measuring mRNA or protein. In certain embodiments the biomarkers are nasal-virus induced molecules.Type: GrantFiled: October 11, 2017Date of Patent: April 23, 2024Assignee: YALE UNIVERSITYInventors: Ellen Foxman, Marie Landry
-
Patent number: 11957931Abstract: In its various aspects and embodiments, the invention comprises a method for treating vitiligo in a patient comprising administering a composition comprising an effective amount of at least one Janus kinase inhibitor and phototherapy.Type: GrantFiled: April 26, 2018Date of Patent: April 16, 2024Assignees: YALE UNIVERSITY, UNIVERSITY OF MASSACHUSETTSInventors: Brett King, John E. Harris
-
Patent number: 11953505Abstract: Various aspects and embodiments of the present disclosure are directed to methods and compositions (e.g., kits) for the identification of subjects with misfolded proteins in their urine. For example, methods and compositions for determining that a urine sample from a pregnant woman contains or does not contain misfolded are provided. In some embodiments, the presence of misfolded proteins in a urine sample from a pregnant woman is an indication of preeclampsia.Type: GrantFiled: June 29, 2021Date of Patent: April 9, 2024Assignee: Yale UniversityInventors: Irina Buhimschi, Catalin S. Buhimschi, Michael Choma, Hemant Tagare, Stephan Michael Jonas
-
Patent number: 11951211Abstract: A method for producing uniform-size liposomes is provided. The liposomes are coated with a sorting agent to yield a plurality of density-modified liposomes of different sizes. These liposomes are then separated using a densitometric method. The sorting agent includes both a density-modifying moiety and a targeting moiety.Type: GrantFiled: January 29, 2021Date of Patent: April 9, 2024Assignee: YALE UNIVERSITYInventors: Chenxiang Lin, Yang Yang
-
Patent number: 11951246Abstract: A method of coaching a patient to use an inhaler for medication delivery is provided. The method includes obtaining, via a sensor, respiratory behavior data of the patient; receiving, at a computing device, the respiratory behavior data; performing a respiratory pattern analysis algorithm on the respiratory behavior data to determine a desired interval of inhaler actuation for medication delivery; communicating a cue signal to actuate the inhaler to achieve the desired interval; obtaining, via the sensor, inhaler actuation data based on the actuation of the inhaler; receiving, at the computing device, the inhaler actuation data; performing an actuation analysis algorithm on the inhaler actuation data to assess the efficacy of the actuation; and adjusting the cue signal to actuate the inhaler to improve the efficacy of a future actuation.Type: GrantFiled: September 27, 2023Date of Patent: April 9, 2024Assignee: Yale UniversityInventor: Peter Kahn
-
Patent number: 11938445Abstract: The present disclosure relates, in part, to enhanced weathering systems and/or apparatuses and methods of use thereof. In one aspect, the present disclosure provides a method of at least partially sequestering CO2 from an influent aqueous solution comprising aqueous and/or gaseous CO2. In another aspect, the present disclosure provides a method of at least partially sequestering CO2 from a gaseous CO2 source. In another aspect, the present disclosure provides systems and/or apparatuses suitable for use in the methods described herein. In another aspect, the present disclosure provides a method of optimizing the design and operation of a system for at least partial sequestration of CO2 from a water source.Type: GrantFiled: April 10, 2023Date of Patent: March 26, 2024Assignee: YALE UNIVERSITYInventors: Joachim Katchinoff, Noah Planavsky, Jacob Jordan, Dean Takahashi, Sinead Crotty, Justin Freiberg
-
Publication number: 20240095569Abstract: Techniques are described for detecting when background radiation has impacted a qubit without the need for additional hardware. In particular, a quantum system may operate readout hardware to read the state of a qubit in addition to operating the readout hardware to detect when an impact has occurred. Readouts from impacted qubits can then be ignored during error correction, and those qubits reset for subsequent operations. In some cases, a readout resonator coupled to a qubit can be implemented as a readout resonator with a high kinetic inductance.Type: ApplicationFiled: September 12, 2023Publication date: March 21, 2024Applicant: Yale UniversityInventors: Max Hays, Michel Devoret
-
Publication number: 20240082215Abstract: The present invention relates to the use of mavoglurant in the treatment of gambling disorder. The present invention also relates to the use of mavoglurant in the treatment of gaming disorder.Type: ApplicationFiled: December 9, 2021Publication date: March 14, 2024Applicants: Novartis AG, Yale UniversityInventors: Fabrizio GASPARINI, Baltazar GOMEZ-MANCILLA, John KRYSTAL, Vincent MALATERRE, Stephanie O'MALLEY, Godfrey PEARLSON, Marc POTENZA
-
Patent number: 11926839Abstract: The present invention includes compositions and methods for T cell genome editing and screening in vivo. In certain aspects, the invention includes an sgRNA library for genome-scale mutagenesis.Type: GrantFiled: April 17, 2018Date of Patent: March 12, 2024Assignee: YALE UNIVERSITYInventors: Sidi Chen, Matthew Dong
-
Patent number: 11920172Abstract: The present invention relates to chimeric (preferably, bifunctional) compounds, compositions comprising those compounds and methods of treating cancer in a patient or subject, especially including metastatic cancer where cancer cells exhibit overexpression (heightened expression) of cell surface urokinase-type plasminogen activator receptor (urokinase receptor) compared to normal (non-cancerous) cells. The compounds preferably covalently bind to the urokinase receptor and recruit native antibodies of the patient or subject where the antibodies can selectively degrade and/or deactivate targeted cancer cells through antibody-dependent cellular phagocytosis and/or antibody-dependent cellular cytotoxicity (ADCC) against a large number and variety of cancers, thus providing cancer cell death and/or an inhibition of growth, elaboration and/or metastasis of the cancer, including remission and cure of the patient's cancer.Type: GrantFiled: February 23, 2021Date of Patent: March 5, 2024Assignee: YALE UNIVERSITYInventors: David A. Spiegel, Charles E. Jakobsche
-
Patent number: 11918695Abstract: Core-shell particles have a hydrophobic core and a shell formed of o containing hyperbranched polymers (HP). The HP can be covalently bound to the one or more materials that form the core or coated thereon. The HP coating can be modified to adjust the properties of the particles. For example, unmodified HP coatings resist non-specific protein absorption. Alternatively, the hydroxyl groups on the HP coating can be chemically modified to form functional groups that react with functional groups on tissue to adhere the particles to the tissue, cells, or extracellular materials, such as proteins. Such functional groups include, but not limited to, aldehydes, amines, and O-substituted oximes. Topical formulation for application to the skin contain these HP coated nanoparticles. In some embodiments, the particles include cosmetic, therapeutic, diagnostic, nutraceutical, and/or prophylactic agents, such as those used as sunblock compositions.Type: GrantFiled: May 11, 2016Date of Patent: March 5, 2024Assignee: YALE UNIVERSITYInventors: Yang Deng, Asiri Ediriwickrema, William M. Saltzman, Michael Girardi
-
Patent number: 11912742Abstract: The present disclosure includes a construct comprising a leupeptin biosynthesis operon, the operon comprising leupA, leupB, leupC, and leupD genes operably linked to a promoter. Also included are cells comprising the construct, and methods for production of leupeptin peptide.Type: GrantFiled: June 30, 2021Date of Patent: February 27, 2024Assignee: YALE UNIVERSITYInventors: Jason Crawford, Jhe-Hao Li, Joonseok Oh
-
Patent number: 11909451Abstract: Systems and methods for performing bosonic quantum error correction (QEC) using Gottesman-Kitaev-Preskill (GKP) states are provided. An ancilla quantum mechanical oscillator is used to probe Gaussian noise experienced by a data quantum mechanical oscillator without disturbing the state of the data quantum mechanical oscillator. The ancilla quantum mechanical oscillator is initialized with a GKP state and entangled with the state of a data quantum mechanical oscillator to correlate any noise experienced by the data state with the state of the ancilla quantum mechanical oscillator. The states are then disentangled, and momentum and position quadrature operators of the ancilla quantum mechanical oscillator are measured and used to perform QEC on the information stored in the data quantum mechanical oscillator.Type: GrantFiled: March 27, 2020Date of Patent: February 20, 2024Assignee: Yale UniversityInventors: Kyungjoo Noh, Steven M. Girvin, Liang Jiang
-
Patent number: 11896639Abstract: The invention relates to methods of evaluating the quality of a batch of an herbal composition, the method comprising subjecting a test batch of the herbal composition to one or more biological analysis methods and comparing the results derived from the test batch to the results of a known batch of herbal composition which has a known in vivo effect.Type: GrantFiled: November 22, 2022Date of Patent: February 13, 2024Assignee: YALE UNIVERSITYInventor: Yung-Chi Cheng
-
Patent number: 11896686Abstract: Core-shell particles and methods of making and using thereof are described herein. The core is formed of or contains one or more hydrophobic materials or more hydrophobic materials. The shell is formed of or contains hyperbranched polyglycerol (HPG). The HPG coating can be modified to adjust the properties of the particles. Unmodified HPG coatings impart stealth properties to the particles which resist non-specific protein absorption and increase circulation in the blood. The hydroxyl groups on the HPG coating can be chemically modified to form functional groups that react with functional groups and adhere the particles to tissue, cells, or extracellular materials, such as proteins.Type: GrantFiled: June 16, 2022Date of Patent: February 13, 2024Assignee: YALE UNIVERSITYInventors: Yang Deng, Asiri Ediriwickrema, William M. Saltzman
-
Patent number: 11890283Abstract: The invention includes methods of preventing or treating acute lung injury using a MAP3K2/MAP3K3 inhibitor. The invention further comprises compositions, and kits comprising compositions useful within the invention.Type: GrantFiled: October 8, 2021Date of Patent: February 6, 2024Assignee: Yale UniversityInventors: Dianqing Wu, Qianying Yuan, Abdul Basit, Wenwen Tang
-
Patent number: 11890335Abstract: Disclosed herein are peptide-adjuvant pharmaceutical compositions and vaccine compositions that trigger long lasting natural anti-tumor antibodies. Such compositions may be used alone, or in combination with anti-cancer agents, chemotherapeutic agents, anti-PD therapy, chemotherapy, radiation therapy, and surgery, in the prevention and treatment of cancer.Type: GrantFiled: September 27, 2018Date of Patent: February 6, 2024Assignees: L2 Diagnostics, LLC, Yale UniversityInventors: Mark Mamula, Raymond A. Koski
-
Patent number: 11883369Abstract: The present invention includes a low dose and sustained release formulation of a mitochondrial uncoupling agent The compositions of the invention are useful for preventing or treating a disease or disorder, such as non-alcoholic fatty liver disease, non-alcoholic steatohepatitis, insulin resistance and/or diabetes, in a subject in need thereof.Type: GrantFiled: May 16, 2022Date of Patent: January 30, 2024Assignee: YALE UNIVERSITYInventors: Gerald I. Shulman, Rachel Jamison Perry